Clinical trial
Endometriosis Trial: Study of NBI-56418 in Endometriosis
NCT00109512 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00109512 |
|---|---|
| Title | Endometriosis Trial: Study of NBI-56418 in Endometriosis |
| Official title | A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of NBI-56418 in Endometriosis |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometriosis |
| Intervention type | Drug |
| Interventions | NBI-56418 (GnRH antagonist), placebo |
| Enrollment | 76 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Apr 29, 2005 |
| Last update posted | Feb 22, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: